MedTrace Logo

A Ketamine-assisted Group Therapy Intervention for Spanish-speaking Adults With Depression

NCT06597695 · Status: RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2025-07-28

No results posted yet for this study

Summary

This is a pilot clinical trial to assess the feasibility, safety, and preliminary efficacy of ketamine-assisted group therapy for Spanish-speaking adults with depression

Conditions

Interventions

DRUG

Ketamine-assisted psychotherapy

Ketamine-assisted psychotherapy delivered in a group format

Sponsors & Collaborators

  • Juliana Zambrano, MD, MPH

    lead OTHER

Principal Investigators

  • Juliana Zambrano, MD · Massachusetts General Hospital

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-23
Primary Completion
2026-07-01
Completion
2026-07-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06597695 on ClinicalTrials.gov